JP6861134B2 - Hyaluronic acid production promoter and hyaluronic acid production promoter food - Google Patents
Hyaluronic acid production promoter and hyaluronic acid production promoter food Download PDFInfo
- Publication number
- JP6861134B2 JP6861134B2 JP2017177769A JP2017177769A JP6861134B2 JP 6861134 B2 JP6861134 B2 JP 6861134B2 JP 2017177769 A JP2017177769 A JP 2017177769A JP 2017177769 A JP2017177769 A JP 2017177769A JP 6861134 B2 JP6861134 B2 JP 6861134B2
- Authority
- JP
- Japan
- Prior art keywords
- hyaluronic acid
- sulforaphane
- acid production
- glucoraphanin
- food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229920002674 hyaluronan Polymers 0.000 title claims description 44
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title claims description 43
- 229960003160 hyaluronic acid Drugs 0.000 title claims description 43
- 235000013305 food Nutrition 0.000 title claims description 22
- 238000004519 manufacturing process Methods 0.000 title description 28
- 230000003020 moisturizing effect Effects 0.000 claims description 13
- 239000004480 active ingredient Substances 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- SUVMJBTUFCVSAD-UHFFFAOYSA-N sulforaphane Chemical compound CS(=O)CCCCN=C=S SUVMJBTUFCVSAD-UHFFFAOYSA-N 0.000 description 92
- 229960005559 sulforaphane Drugs 0.000 description 46
- SUVMJBTUFCVSAD-JTQLQIEISA-N 4-Methylsulfinylbutyl isothiocyanate Natural products C[S@](=O)CCCCN=C=S SUVMJBTUFCVSAD-JTQLQIEISA-N 0.000 description 45
- 235000015487 sulforaphane Nutrition 0.000 description 45
- RUQCCAGSFPUGSZ-OBWQKADXSA-N Glucoraphanin Natural products C[S@](=O)CCCCC(=NS(=O)(=O)O)S[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RUQCCAGSFPUGSZ-OBWQKADXSA-N 0.000 description 37
- GMMLNKINDDUDCF-JRWRFYLSSA-N [(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1e)-5-[(r)-methylsulfinyl]-n-sulfooxypentanimidothioate Chemical compound C[S@@](=O)CCCC\C(=N/OS(O)(=O)=O)S[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GMMLNKINDDUDCF-JRWRFYLSSA-N 0.000 description 37
- 241000196324 Embryophyta Species 0.000 description 27
- 239000000047 product Substances 0.000 description 24
- 210000003491 skin Anatomy 0.000 description 20
- 238000002360 preparation method Methods 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- 240000007124 Brassica oleracea Species 0.000 description 9
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 9
- 239000002537 cosmetic Substances 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 6
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 125000004383 glucosinolate group Chemical group 0.000 description 4
- -1 hydroxysulfonyloxy Chemical group 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000000825 pharmaceutical preparation Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 206010013786 Dry skin Diseases 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 230000037336 dry skin Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229940127557 pharmaceutical product Drugs 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 2
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 2
- 241000219193 Brassicaceae Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 210000001339 epidermal cell Anatomy 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 210000001626 skin fibroblast Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 108010058651 thioglucosidase Proteins 0.000 description 2
- JUSMHIGDXPKSID-DVKNGEFBSA-N 1-thio-beta-D-glucopyranose Chemical compound OC[C@H]1O[C@@H](S)[C@H](O)[C@@H](O)[C@@H]1O JUSMHIGDXPKSID-DVKNGEFBSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920001612 Hydroxyethyl starch Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QKGJFQMGPDVOQE-UHFFFAOYSA-N Sulforaphen Natural products CS(=O)C=CCCN=C=S QKGJFQMGPDVOQE-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- CEIPQQODRKXDSB-UHFFFAOYSA-N ethyl 3-(6-hydroxynaphthalen-2-yl)-1H-indazole-5-carboximidate dihydrochloride Chemical compound Cl.Cl.C1=C(O)C=CC2=CC(C3=NNC4=CC=C(C=C43)C(=N)OCC)=CC=C21 CEIPQQODRKXDSB-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 1
- 229940099552 hyaluronan Drugs 0.000 description 1
- 229940050526 hydroxyethylstarch Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000006216 methylsulfinyl group Chemical group [H]C([H])([H])S(*)=O 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 231100000062 no-observed-adverse-effect level Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- QKGJFQMGPDVOQE-HWKANZROSA-N raphanin Chemical compound CS(=O)\C=C\CCN=C=S QKGJFQMGPDVOQE-HWKANZROSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 210000004127 vitreous body Anatomy 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
本発明はヒアルロン酸の産生を促進するヒアルロン酸産生促進剤に関する。 The present invention relates to a hyaluronic acid production promoter that promotes the production of hyaluronic acid.
ヒアルロン酸は、Ｄ−Ｎ−アセチルグルコサミンとＤ−グルクロン酸が交互に結合して形成された直鎖状の高分子多糖であり、皮膚、軟骨、関節液、臍帯、眼硝子体、その他の結合組織に存在する。このうち、最も多くヒアルロン酸が含まれているのは皮膚である。
皮膚の真皮及び表皮は、表皮細胞、線維芽細胞、及び真皮細胞外マトリックス等によって構成されているが、ヒアルロン酸は、コラーゲン、エラスチン等と共に真皮細胞外マトリックスを構成し、表皮細胞や線維芽細胞等の細胞の外にあって、細胞の保護、組織水分の保持、柔軟性の維持、潤滑性の保持等において重要な役割を担っている。
Hyaluronic acid is a linear high-molecular-weight polysaccharide formed by the alternating combination of DN-acetylglucosamine and D-glucuronic acid, and is a combination of skin, cartilage, articular fluid, umbilical cord, ocular vitreous body, and other bonds. Present in the organization. Of these, the skin contains the largest amount of hyaluronic acid.
The dermis and epidermis of the skin are composed of epidermal cells, fibroblasts, dermal extracellular matrix and the like, but hyaluronic acid constitutes the dermis extracellular matrix together with collagen, elastin and the like, and epidermal cells and fibroblasts. It plays an important role in protecting cells, retaining tissue water, maintaining flexibility, maintaining lubricity, and the like.
皮膚のヒアルロン酸の産生量は、加齢とともに減少することが知られており、その結果、細胞の保湿力を低下させて乾燥、肌荒れ、シミ、皺等の症状を引き起こす原因となる。また、近年、紫外線等の外的要因も、ヒアルロン酸量の減少を誘導する因子とされており、乾燥肌や肌荒れの要因となると考えられる。したがって、ヒアルロン酸産生の促進は、皮膚の保湿機能を維持又は改善する上で重要である。 It is known that the amount of hyaluronic acid produced in the skin decreases with aging, and as a result, the moisturizing power of cells is reduced, causing symptoms such as dryness, rough skin, age spots, and wrinkles. Further, in recent years, external factors such as ultraviolet rays are also considered to be factors that induce a decrease in the amount of hyaluronic acid, and are considered to be factors of dry skin and rough skin. Therefore, promotion of hyaluronic acid production is important for maintaining or improving the moisturizing function of the skin.
そこで、ヒアルロン酸産生を促進する素材を天然物から探索する試みがなされ、植物の抽出物（特許文献１、特許文献２）やその成分（特許文献３）の他、種々の物質にヒアルロン酸産生促進作用があることがこれまでに報告されている。 Therefore, an attempt was made to search for a material that promotes hyaluronic acid production from natural products, and hyaluronic acid production was produced in various substances in addition to plant extracts (Patent Document 1 and Patent Document 2) and their components (Patent Document 3). It has been reported so far that it has a promoting effect.
一方、ブロッコリー等のアブラナ科の植物には、スルフォラファンの前駆体グルコシノレートであるグルコラファニンが多く含まれ、当該植物の組織中に含まれるグルコラファニンは、組織が破壊されると内在性の酵素ミロシナーゼにより加水分解され、スルフォラファンを生じることが知られている（非特許文献１）。また、ヒトがグルコラファニンを摂取した場合においても、腸内細菌の働きによって、スルフォラファンに変換されて、腸管から吸収されると考えられている。 On the other hand, cruciferous plants such as broccoli contain a large amount of glucosinolate, which is a precursor of sulforaphane, and glucoraphanin contained in the tissue of the plant is endogenous when the tissue is destroyed. It is known that sulforaphane is produced by being hydrolyzed by the enzyme myrosinase (Non-Patent Document 1). It is also believed that when humans ingest glucoraphanin, it is converted to sulforaphane by the action of intestinal bacteria and absorbed from the intestinal tract.
斯かるスルフォラファンやその前駆体グルコシノレートであるグルコラファニンには、体内の代謝過程で生じる発ガン物質の活性化を打消す第二相解毒酵素を強く誘導する作用があること、ガン治療に対して有効であること（特許文献４）等が報告されている。
しかしながら、グルコラファニンやスルフォラファンにヒアルロン酸産生促進作用や皮膚の保湿機能を改善する作用があることはこれまでに知られていない。
Such sulforaphane and its precursor glucosinolate, glucosinolate, have the effect of strongly inducing a phase II detoxifying enzyme that counteracts the activation of carcinogens that occur in the metabolic process in the body. It has been reported that it is effective against this (Patent Document 4).
However, it has not been known so far that glucoraphanin and sulforaphane have an action of promoting hyaluronic acid production and an action of improving the moisturizing function of the skin.
本発明の課題は、安全性が高く、長期に適用可能なヒアルロン酸産生促進剤を提供することにある。 An object of the present invention is to provide a hyaluronic acid production promoter that is highly safe and can be applied for a long period of time.
本発明者は、多くの天然物の中からヒアルロン酸産生促進剤を見出すべく検討した結果、グルコラファニン及びスルフォラファンが線維芽細胞におけるヒアルロン酸産生を促進する作用があることを見出し、本発明を完成した。 As a result of studying to find a hyaluronic acid production promoter among many natural products, the present inventor has found that glucorafanine and sulforaphane have an action of promoting hyaluronic acid production in fibroblasts, and the present invention has been developed. completed.
すなわち、本発明は、以下の１）〜４）に係るものである。
１）グルコラファニン及び／又はスルフォラファン、又はこれを含有する植物若しくはその加工品を有効成分とするヒアルロン酸産生促進剤。
２）グルコラファニン及び／又はスルフォラファン、又はこれを含有する植物若しくはその加工品を有効成分とするヒアルロン酸産生促進用食品。
３）グルコラファニン及び／又はスルフォラファン、又はこれを含有する植物若しくはその加工品を有効成分とする皮膚保湿機能改善剤。
４）グルコラファニン及び／又はスルフォラファン、又はこれを含有する植物若しくはその加工品を有効成分とする皮膚保湿機能改善用食品。
That is, the present invention relates to the following 1) to 4).
1) A hyaluronic acid production promoter containing glucoraphanin and / or sulforaphane, a plant containing the sulforaphane, or a processed product thereof as an active ingredient.
2) A food for promoting hyaluronic acid production containing glucoraphanin and / or sulforaphane, a plant containing the same, or a processed product thereof as an active ingredient.
3) A skin moisturizing function improving agent containing glucoraphanin and / or sulforaphane, a plant containing the same, or a processed product thereof as an active ingredient.
4) A food for improving skin moisturizing function containing glucoraphanin and / or sulforaphane, a plant containing the same, or a processed product thereof as an active ingredient.
グルコラファニン及びスルフォラファンは、ブロッコリーやケールから容易に取得可能であり、長期投与又は摂取可能である。したがって、本発明によれば、安全性の高いヒアルロン酸産生促進剤が提供され、ヒアルロン酸の減少に起因する皮膚保湿機能の低下、それに伴う乾燥肌、肌荒れの予防又は改善効果が奏される。 Glucoraphanin and sulforaphane can be easily obtained from broccoli and kale, and can be administered or ingested for a long period of time. Therefore, according to the present invention, a highly safe hyaluronic acid production promoter is provided, and the effect of preventing or improving the skin moisturizing function due to the decrease of hyaluronic acid and the accompanying dry skin and rough skin is exhibited.
本発明のグルコラファニン（Ｇｌｕｃｏｒａｐｈａｎｉｎ）は、別名：１−チオ−β−Ｄ−グルコピラノース１−［Ｎ−（ヒドロキシスルホニルオキシ）−５−（メチルスルフィニル）ペンタンイミダート］であり、スルフォラファン（Ｓｕｌｆｏｒａｐｈａｎｅ）は４−（メチルスルフィニル）ブチルイソチオシアナートである。
前述したとおり、グルコラファニンは、スルフォラファンの前駆体グルコシノレートであり、アブラナ科植物中で酵素ミロシナーゼにより加水分解されてスルフォラファンを生じる。また、ヒトがグルコラファニンを摂取した場合においても、スルフォラファンに変換されて、腸管から吸収される。
The glucoraphanin of the present invention is also known as 1-thio-β-D-glucopyranose 1- [N- (hydroxysulfonyloxy) -5- (methylsulfinyl) pentane imidate] and sulforaphane. ) Is 4- (methylsulfinyl) butyl isothiocyanate.
As mentioned above, glucoraphanin is a precursor glucosinolate of sulforaphane and is hydrolyzed by the enzyme myrosinase in cruciferous plants to produce sulforaphane. Also, when humans ingest glucoraphanin, it is converted to sulforaphane and absorbed from the intestinal tract.
グルコラファニン及びスルフォラファンは、グルコラファニン及び／又はスルフォラファンを含有する植物から公知の方法で単離精製することにより取得することができる。 Glucoraphanin and sulforaphane can be obtained by isolation and purification from plants containing glucoraphanin and / or sulforaphane by a known method.
グルコラファニン及び／又はスルフォラファンを含有する植物としては、例えばアブラナ科（Ｂｒａｓｓｉｃａｃｅａｅ）植物、好ましくはアブラナ科アブラナ属（Ｂｒａｓｓｉｃａ）の植物が例示される。具体的には、ケール、ブロッコリー、カリフラワー、キャベツ等が挙げられる。これらの植物においては、グルコラファニン又はスルフォラファンの含有量の点で、ケールやキャベツではその葉や茎、ブロッコリーやカリフラワーではその花蕾を使用することが望ましい。ケールの品種は、ハイパール（農林水産省品種登録第２０５５５号）、ハイクロップ、エステ、エキストラ・カールド・スコッチ等が利用できる。また、グルコラファニン又はスルフォラファンの含有量を高めたケールに属する新品種を使用することもできる。さらに、グルコラファニン又はスルフォラファンの含有量を指標とすることで、ヒアルロン酸産生促進作用が高いケールに属する新品種の開発を行うこともできる。 Examples of plants containing glucoraphanin and / or sulforaphane include, for example, Brassicaceae plants, preferably Brassicaceae plants. Specific examples include kale, broccoli, cauliflower, cabbage and the like. In these plants, in terms of glucoraphanin or sulforaphane content, it is desirable to use their leaves and stems for kale and cabbage, and their flower buds for broccoli and cauliflower. As kale varieties, Hyperle (Ministry of Agriculture, Forestry and Fisheries Variety Registration No. 20555), High Crop, Esthetics, Extra Carled Scotch, etc. can be used. It is also possible to use new varieties belonging to kale with an increased content of glucoraphanin or sulforaphane. Furthermore, by using the content of glucoraphanin or sulforaphane as an index, it is possible to develop a new variety belonging to kale having a high hyaluronic acid production promoting action.
また、単離精製されたグルコラファニン及びスルフォラファンは市販されており、本発明においては、当該市販品を使用することもできる。 In addition, isolated and purified glucoraphanin and sulforaphane are commercially available, and the commercially available products can also be used in the present invention.
本発明において、グルコラファニン又はスルフォラファンは、単離されたグルコラファニン、スルフォラファンのみならず、上記のグルコラファニン又はスルフォラファンを含有する植物又はその加工品（例えば、該植物の粉砕物、該植物の凍結乾燥物、該植物の搾汁、該植物の抽出物等）を使用することができる。例えば、ケール搾汁物やその乾燥物等が使用可能である。 In the present invention, the glucoraphanin or sulforaphane is not only the isolated glucoraphanin and sulforaphane, but also a plant containing the above-mentioned glucoraphanin or sulforaphane or a processed product thereof (for example, a pulverized product of the plant, the plant). Sulforaphane, squeezed plant juice, extract of the plant, etc.) can be used. For example, kale soup and dried products thereof can be used.
グルコラファニン及び／又はスルフォラファンを含有する植物の加工品、すなわちその粉砕物、凍結乾燥物、及び搾汁は、当業者によって通常用いられる処理方法で、上記植物を処理することにより得ることができる。また、抽出物は、上記の植物から当業者によって通常用いられる抽出処理方法によって得ることができる。例えば、当該植物を粉砕し、水又は含水溶媒（水−アルコール混合溶液等）で含浸又は抽出する方法が挙げられる。 Processed products of plants containing glucoraphanin and / or sulforaphane, ie, crushed products, lyophilized products, and juices thereof, can be obtained by treating the above plants by a treatment method usually used by those skilled in the art. .. In addition, the extract can be obtained from the above plants by an extraction treatment method usually used by those skilled in the art. For example, a method of crushing the plant and impregnating or extracting it with water or a water-containing solvent (water-alcohol mixed solution, etc.) can be mentioned.
斯くして得られた植物の加工品は、必要に応じて、合成吸着剤による処理、ろ過処理、濃縮処理等の分離・精製工程に供することにより、グルコラファニン及び／又はスルフォラファンの含有割合を高めてもよい。 The processed plant product thus obtained is subjected to a separation / purification step such as treatment with a synthetic adsorbent, filtration treatment, concentration treatment, etc., if necessary, so that the content ratio of glucorafanine and / or sulforaphane can be adjusted. You may increase it.
本発明のグルコラファニン及びスルフォラファンは、後記実施例に示すように、正常ヒト皮膚線維芽細胞におけるヒアルロン酸産生を促進する。したがって、グルコラファニン及び／又はスルフォラファン、又はこれを含有する植物若しくはその加工品は、ヒアルロン酸産生促進剤となり、ヒアルロン酸産生促進のために使用できる。
本発明において、ヒアルロン酸の産生促進とは、ヒト皮膚真皮の繊維芽細胞のヒアルロン酸の産生能を促進または改善し、これにより、ヒト皮膚においてヒアルロン酸量が増大し得ることを意味する。皮膚のヒアルロン酸量を増加させることによって、皮膚保湿機能が維持・改善され、乾燥肌、肌荒れの予防又は改善に効果を奏する。したがって、グルコラファニン及び／又はスルフォラファン、又はこれを含有する植物若しくはその加工品は、皮膚保湿機能改善剤にもなり得る。
The glucoraphanin and sulforaphane of the present invention promote hyaluronic acid production in normal human skin fibroblasts, as shown in Examples below. Therefore, glucoraphanin and / or sulforaphane, or a plant containing the same or a processed product thereof, becomes a hyaluronic acid production promoter and can be used for promoting hyaluronic acid production.
In the present invention, promoting the production of hyaluronic acid means promoting or improving the ability of fibroblasts of human skin dermis to produce hyaluronic acid, thereby increasing the amount of hyaluronic acid in human skin. By increasing the amount of hyaluronic acid in the skin, the skin moisturizing function is maintained and improved, and it is effective in preventing or improving dry skin and rough skin. Therefore, glucoraphanin and / or sulforaphane, or a plant containing it or a processed product thereof, can also be a skin moisturizing function improving agent.
上記ヒアルロン酸産生促進剤は、ヒアルロン酸産生を促進するため、皮膚保湿機能を改善するための医薬品、医薬部外品、化粧品、サプリメント又は食品（ヒアルロン酸産生促進用食品、皮膚保湿機能改善用食品）となり、或いはこれらへ配合するための素材又は製剤となり得る。また、本発明のグルコラファニン及びスルフォラファンは何れも経口摂取した場合に体内に吸収されることから、細胞評価試験の結果と同じ効果を奏すると考えられる。
尚、上記食品には、一般飲食品のほか、ヒアルロン酸産生、皮膚保湿機能改善をコンセプトとし、必要に応じてその旨を表示した食品、機能性表示食品、特定保健用食品等が包含される。
Since the above hyaluronic acid production promoter promotes hyaluronic acid production, pharmaceuticals, non-pharmaceutical products, cosmetics, supplements or foods for improving skin moisturizing function (hyaluronic acid production promoting food, skin moisturizing function improving food) ), Or it can be a material or formulation to be incorporated into these. In addition, since both glucoraphanin and sulforaphane of the present invention are absorbed into the body when ingested orally, it is considered that they have the same effect as the result of the cell evaluation test.
In addition to general foods and drinks, the above foods include foods with the concept of hyaluronic acid production and improvement of skin moisturizing function, and foods labeled to that effect, foods with functional claims, foods for specified health use, etc. as necessary. ..
本発明のグルコラファニン及びスルフォラファンを含む上記医薬品（医薬部外品を含む）は、任意の投与形態で投与され得る。投与に際しては、有効成分を経口、直腸内、注射、外用等の投与方法に適した固体又は液体の医薬用無毒性担体と混合して、慣用の医薬品製剤の形態で投与することができる。 The above-mentioned pharmaceutical products (including quasi-drugs) containing glucoraphanin and sulforaphane of the present invention can be administered in any dosage form. Upon administration, the active ingredient can be mixed with a solid or liquid NOAEL suitable for administration methods such as oral, rectal, injection, and external use, and administered in the form of a conventional pharmaceutical preparation.
例えば、経口投与製剤としては、錠剤、顆粒剤、散剤、カプセル剤等の固形剤、溶液剤、懸濁剤、乳剤等の液剤、凍結乾燥剤等が挙げられる。これらの製剤は製剤上の常套手段により調製することができる。上記の医薬用無毒性担体としては、例えば、グルコース、乳糖、ショ糖、澱粉、マンニトール、デキストリン、脂肪酸グリセリド、ポリエチレングリコール、ヒドロキシエチルデンプン、エチレングリコール、ポリオキシエチレンソルビタン脂肪酸エステル、アミノ酸、ゼラチン、アルブミン、水、生理食塩水等が挙げられる。また、必要に応じて、安定化剤、湿潤剤、乳化剤、結合剤、等張化剤、賦形剤等の慣用の添加剤を適宜添加することもできる。 For example, examples of the orally administered preparation include solid preparations such as tablets, granules, powders and capsules, solutions, suspensions, liquid preparations such as emulsions, lyophilizers and the like. These formulations can be prepared by conventional means of formulation. Examples of the above-mentioned pharmaceutical non-toxic carrier include glucose, lactose, sucrose, starch, mannitol, dextrin, fatty acid glyceride, polyethylene glycol, hydroxyethyl starch, ethylene glycol, polyoxyethylene sorbitan fatty acid ester, amino acid, gelatin and albumin. , Water, physiological saline and the like. Further, if necessary, conventional additives such as stabilizers, wetting agents, emulsifiers, binders, isotonic agents, and excipients can be appropriately added.
また、外用剤（化粧品、医薬品および医薬部外品を含む。）の形態としては、軟膏剤、クリーム剤、外用液剤の他、各種化粧品の形態（例えば、化粧水、乳液、各種クリーム、パック、美容液等の基礎化粧料、シャンプー、リンス、トリートメント、ヘアトニック、ヘアリキッド、ヘアクリーム、ヘアミルク等の頭髪用製品、入浴剤等の浴用化粧品、ファンデーション、口紅、マスカラ、アイシャドウ等のメーキャップ化粧品、日焼け止め等）が挙げられる。 The forms of external preparations (including cosmetics, pharmaceuticals, and quasi-drugs) include ointments, creams, and external liquids, as well as various cosmetic forms (for example, cosmetics, milky lotions, various creams, packs, etc.). Basic cosmetics such as beauty liquids, shampoos, rinses, treatments, hair tonics, hair liquids, hair creams, hair milk and other hair products, bath cosmetics such as bathing agents, foundations, lipsticks, mascara, eye shadows and other makeup cosmetics, (Sunscreen, etc.).
また、上記外用剤には、必須成分であるグルコラファニン及び／又はスルフォラファン、又はこれを含有する植物若しくはその加工品の他に、通常、外用剤に配合される任意成分を配合することができる。このような任意成分としては、界面活性剤、油分、アルコール類、保湿剤、増粘剤、防腐剤、酸化防止剤、キレート剤、ｐＨ調整剤、香料、色素、紫外線吸収・散乱剤、粉体、ビタミン類、アミノ酸類、水溶性高分子、発泡剤、顔料、植物抽出物、動物由来成分、海藻抽出物、各種薬剤、添加剤、水等を挙げることができる。 Further, in addition to the essential components glucorafanine and / or sulforaphane, or a plant containing the same or a processed product thereof, the external preparation may contain any component usually contained in the external preparation. .. Such optional components include surfactants, oils, alcohols, moisturizers, thickeners, preservatives, antioxidants, chelating agents, pH regulators, fragrances, pigments, ultraviolet absorbers / scattering agents, and powders. , Vitamins, amino acids, water-soluble polymers, foaming agents, pigments, plant extracts, animal-derived components, seaweed extracts, various chemicals, additives, water and the like.
また、グルコラファニン及び／又はスルフォラファン、又はこれを含有する植物若しくはその加工品を配合した上記食品の形態は、各種食品組成物の他、上述した経口投与製剤と同様の形態（錠剤、カプセル剤、シロップ等）が挙げられる。
種々の形態の食品を調製するには、本発明のグルコラファニン及び／又はスルフォラファン、又はこれを含有する植物若しくはその加工品を単独で、又は他の食品材料や、溶剤、軟化剤、油、乳化剤、防腐剤、香科、安定剤、着色剤、酸化防止剤、保湿剤、増粘剤等を適宜組み合わせて用いることができる。
In addition, the form of the above-mentioned food containing glucoraphanin and / or sulforaphane, or a plant containing the same or a processed product thereof is the same as the above-mentioned orally-administered preparation (tablets, capsules) in addition to various food compositions. , Syrup, etc.).
To prepare various forms of foods, the glucoraphanin and / or sulforaphane of the present invention, or plants containing them or processed products thereof alone, or other food materials, solvents, softeners, oils, etc. Emulsifiers, preservatives, fragrances, stabilizers, colorants, antioxidants, moisturizers, thickeners and the like can be used in appropriate combinations.
上記の医薬品（医薬部外品を含む）、化粧品及び食品中のグルコラファニン及び／又はスルフォラファン、又はこれを含有する植物若しくはその加工品の含有量は、その使用形態により異なるが、通常、グルコラファニン及び／又はスルフォラファンとして、製剤全質量の０．０１〜１０質量％、好ましくは０．１〜１質量％ある。 The content of glucoraphanin and / or sulforaphane in the above-mentioned pharmaceutical products (including quasi-drugs), cosmetics and foods, or plants containing them or processed products thereof varies depending on the usage pattern, but is usually gluco. As raphanin and / or sulforaphane, it is 0.01 to 10% by mass, preferably 0.1 to 1% by mass, based on the total mass of the preparation.
本発明のグルコラファニン及び／又はスルフォラファン、又はこれを含有する植物若しくはその加工品を医薬品、化粧品又は食品として、或いは医薬品や食品に配合して使用する場合の投与量は、患者の状態、体重、性別、年齢又はその他の要因に従って変動し得るが、経口投与の場合の成人１人当たりの１日の投与量は、通常、グルコラファニン及び／又はスルフォラファンとして、好ましくは０．１ｍｇ〜１００ｇ、より好ましくは１ｍｇ〜１０ｇである。
また、上記製剤は、任意の投与計画に従って投与され得るが、１日１回〜数回に分け、数週間〜数ヶ月間継続して投与することが好ましい。
When the glucoraphanin and / or sulforaphane of the present invention, or a plant containing the same, or a processed product thereof is used as a drug, cosmetics or food, or in combination with a drug or food, the dose is determined by the patient's condition and body weight. The daily dose per adult for oral administration is usually 0.1 mg to 100 g, preferably 0.1 mg to 100 g, as glucoraphanin and / or sulforaphane, although it may vary depending on gender, age or other factors. It is preferably 1 mg to 10 g.
The preparation may be administered according to an arbitrary administration plan, but it is preferably administered once to several times a day and continuously for several weeks to several months.
実施例１．ヒアルロン酸産生促進作用の評価
（１）試験品
・グルコラファニン：Ｇｌｕｃｏｒａｐｈａｎｉｎ、 Ｃａｙｍａｎ Ｃｈeｍｉｃａｌ社
・スルフォラファン：Ｒ，Ｓ−Ｓｕｌｆｏｒａｐｈａｎｅ、ＬＫＴ Ｌａｂｏｒａｔｏｒｉｅｓ社
Example 1. Evaluation of hyaluronic acid production promoting action (1) Test product ・ Glucoraphanin: Glucoraphanin, Cayman Chemical Co., Ltd. ・ Sulforaphane: R, S-Sulforaphane, LKT Laboratories
（２）細胞及び培養条件
細胞株：正常ヒト皮膚線維芽細胞（ＮＨＤＦ、クラボウ）
細胞は、３７℃、５％二酸化炭素の雰囲気下にて培養を行った。培地は、Ｄｕｌｂｅｃｃｏ’ｓ Ｍｏｄｉｆｉｅｄ Ｅａｇｌｅ Ｍｅｄｉｕｍ（Ｌｉｆｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ社）を使用した。
(2) Cell and culture conditions
Cell line: Normal human skin fibroblasts (NHDF, Kurabo Industries)
The cells were cultured in an atmosphere of 37 ° C. and 5% carbon dioxide. As the medium, Dulbecco's Modified Eagle Medium (Life Technologies) was used.
（３）試験品溶液の調製
エタノールにグルコラファニン、スルフォラファンを各々溶解し、以下に示す濃度の試験品溶液を調製した。
・グルコラファニン：１５．６２５、３．９０６μｇ／ｍＬ
・スルフォラファン：０．３９、０．０９７μｇ／ｍＬ
(3) Preparation of test product solution Glucoraphanin and sulforaphane were dissolved in ethanol to prepare a test product solution having the following concentrations.
Glucoraphanin: 15.625, 3.906 μg / mL
-Sulforaphane: 0.39, 0.097 μg / mL
（４）ヒアルロン酸産生試験
ＮＨＤＦを９６ｗｅｌｌ ｍｉｃｒｏ ｐｌａｔｅに１×１０４ｃｅｌｌｓ／１００μＬ／ｗｅｌｌの濃度で播種し、２４時間、前培養した。前培養後、上記で調製した各試験品溶液を各ｗｅｌｌに加え４８時間の培養を行った。培養上清を回収し、ＥＬＩＳＡ法（Ｈｙａｌｕｒｏｎａｎ Ｑｕａｎｔｉｋｉｎｅ ＥＬＩＳＡ Ｋｉｔ（Ｒ＆Ｄ Ｓｙｓｔｅｍｓ社））にてヒアルロン酸量を測定した。試験品未添加群（コントロール）のヒアルロン酸量を１００％として、各試験品添加群のヒアルロン酸量産生率を、全細胞の総タンパク質量を測定しタンパク質量当たりのヒアルロン酸産生量で求めた。試験は、３回実施しその平均値を算出した（ｎ＝３）。
(4) Hyaluronic acid production test
NHDF was seeded on a 96- well microplate at a concentration of 1 × 10 4 cells / 100 μL / well and pre-cultured for 24 hours. After the pre-culture, each test product solution prepared above was added to each well and cultured for 48 hours. The culture supernatant was collected, and the amount of hyaluronic acid was measured by an ELISA method (Hyaluronan Quantikine ELISA Kit (R & D Systems)). The amount of hyaluronic acid produced in each test product-added group was determined by measuring the total protein amount of all cells and calculating the amount of hyaluronic acid produced per protein amount, assuming that the amount of hyaluronic acid in the test product-free group (control) was 100%. .. The test was carried out three times and the average value was calculated (n = 3).
（５）結果
結果を図１及び２に示す。
グルコラファニン及びスルフォラファンには、コントロールと比較して有意なヒアルロン酸産生率の増加が認められた。
(5) Results The results are shown in FIGS. 1 and 2.
Glucoraphane and sulforaphane showed a significant increase in hyaluronic acid production rate compared to the control.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017177769A JP6861134B2 (en) | 2017-09-15 | 2017-09-15 | Hyaluronic acid production promoter and hyaluronic acid production promoter food |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017177769A JP6861134B2 (en) | 2017-09-15 | 2017-09-15 | Hyaluronic acid production promoter and hyaluronic acid production promoter food |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019052113A JP2019052113A (en) | 2019-04-04 |
| JP6861134B2 true JP6861134B2 (en) | 2021-04-21 |
Family
ID=66014319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017177769A Active JP6861134B2 (en) | 2017-09-15 | 2017-09-15 | Hyaluronic acid production promoter and hyaluronic acid production promoter food |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6861134B2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114748418B (en) * | 2022-04-28 | 2023-04-11 | 赣州华汉生物科技有限公司 | Sulforaphane oil suspension and preparation method thereof |
| CN114983963A (en) * | 2022-05-17 | 2022-09-02 | 上海玖思实业有限公司 | Preparation method of sulforaphane soft capsules |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3502808B2 (en) * | 2000-04-26 | 2004-03-02 | 石川県 | Cosmetics |
| KR101972071B1 (en) * | 2011-02-18 | 2019-04-24 | (주)아모레퍼시픽 | Cosmetic composition for improving skin tone or skin elasticity |
| US10172772B2 (en) * | 2013-01-31 | 2019-01-08 | KGK Science, Inc. | Methods of skin whitening by use of canola extracts |
| KR101787074B1 (en) * | 2016-02-01 | 2017-10-18 | 이성표 | Cosmetic compositions comprising mixed extracts of natural products for skin-whitening and improving skin-wrinkle |
-
2017
- 2017-09-15 JP JP2017177769A patent/JP6861134B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019052113A (en) | 2019-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI438002B (en) | Type I Collagen Production Promote Oral Agent | |
| JP2003238432A (en) | Hyaluronic acid acuumulation-accelerating agent | |
| JPWO2004016236A1 (en) | Cosmetics | |
| JP2016088933A (en) | Age production inhibitor and application thereof | |
| JP4388289B2 (en) | Skin aging prevention / improving agent and / or rough skin prevention / improving agent kit | |
| JPWO2004085429A1 (en) | Composition for promoting type I collagen and / or elastin production | |
| JP4286513B2 (en) | Anti-aging composition | |
| KR20200121828A (en) | Anti-pollution agent and composition for external skin | |
| JP6482930B2 (en) | Skin cosmetics and foods and drinks | |
| JP6861134B2 (en) | Hyaluronic acid production promoter and hyaluronic acid production promoter food | |
| JP4420358B1 (en) | Hyaluronic acid production promoter | |
| JP2011195473A (en) | Hyaluronic acid-production promotor | |
| JP4420357B1 (en) | Hyaluronic acid production promoter | |
| JP6055667B2 (en) | Collagen production promoter | |
| JP6026717B2 (en) | Hyaluronic acid production promoter | |
| JP4247091B2 (en) | Skin anti-aging agent | |
| KR101914441B1 (en) | Cosmetic compositions for improving skin moisturizing comprising fucosterol | |
| JP2004091396A (en) | Bleaching agent | |
| JP2019052114A (en) | Collagen production promoter and collagen production promoting food | |
| KR20180082058A (en) | A cosmetic composition for skin desquamation comprising natural complex extract | |
| JP2017132747A (en) | Age production inhibitor | |
| JP2003342179A (en) | Agent for aging prevention | |
| KR20170045085A (en) | Composition for improving skin and its use | |
| KR20160054672A (en) | Composition for promoting synthesis of hyaluronic acid comprising Hordeum vulgare extracts and the use thereof | |
| JP6947484B2 (en) | Innate immunity activator |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190627 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200623 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20200813 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201014 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210323 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210329 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6861134 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |